# Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma

> **NCT06670976** · PHASE1 · WITHDRAWN · sponsor: **Roswell Park Cancer Institute**

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Positron Emission Tomography
- **DRUG:** Propranolol
- **RADIATION:** Radiation Therapy
- **PROCEDURE:** Surgical Procedure

## Key facts

- **NCT ID:** NCT06670976
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-05-15
- **Primary completion:** 2029-11-15
- **Final completion:** 2029-11-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** to be submitted at a later date
- **Last updated:** 2025-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06670976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06670976, "Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06670976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*